Actuate Therapeutics

Fort Worth, United States

Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases.

Nov 2025

Post-IPO Equity

Biotechnology Medical Oncology Pharmaceutical

Top Investors

Kairos VenturesDEFTA PartnersTCA Venture GroupBios PartnersCraig-Hallum Capital Group

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Actuate Therapeutics

Who are Actuate Therapeutics's investors?

Actuate Therapeutics's investors include Kairos Ventures, DEFTA Partners, TCA Venture Group, Bios Partners, Craig-Hallum Capital Group.

Where is Actuate Therapeutics headquartered?

Actuate Therapeutics is headquartered in Fort Worth, United States.

What does Actuate Therapeutics do?

Actuate Therapeutics provides advanced research for the treatment of high-impact cancers and neurodegenerative diseases.

What stage is Actuate Therapeutics at?

Actuate Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 28, 2025.

MLA

"Actuate Therapeutics — Funding & Investors." VCBacked, November 28, 2025, https://www.vcbacked.co/company/actuate-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2025). Actuate Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/actuate-therapeutics

Wikipedia (cite web)

{{cite web |title=Actuate Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/actuate-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 28, 2025.